Concepedia

Author

Pierre Chan

University of Hong Kong

Also Known As

A.P.C. Chan, P.T.I. Lam, D.W.M. Chan, E. Cheung & Y. Ke, Pierre Chan

40

Publications

1.8K

Citations

24

H-Index

24

Concepts

All Affiliations

University of Hong KongQueen Mary HospitalChinese University of Hong KongRuttonjee HospitalMarymount University
PC

About

Pierre Chan is an author at University of Hong Kong specializing in medicine, oncology, and gastroenterology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

315

2

Gastroenterology

3

3

59

3

Pathology

3

3

71

4

Health Sciences

1

1

17

5

Hepatology

1

1

17

Pierre Chan

×

25

Publications

1.5K

Citations

21

H-Index

YearCitations

Prevalence of Colorectal Neoplasm Among Patients With Newly Diagnosed Coronary Artery Disease

Annie On On Chan, Man Hong Jim, Kwok Fai Lam,

JAMA

2007

156

Phase 2 open‐label study of single‐agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B–endemic Asian population

Thomas Yau, Pierre Chan, Kelvin K. Ng,

Cancer

2008

142

Famotidine Is Inferior to Pantoprazole in Preventing Recurrence of Aspirin-Related Peptic Ulcers or Erosions

Fook–Hong Ng, Siu‐Yin Wong, Kwok–Fai Lam,

Gastroenterology

2009

121

The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

Thomas Yau, Tzy‐Jyun Yao, Pierre Chan,

The Oncologist

2011

108

A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma

Thomas Yau, Paul N. Cheng, Pierre Chan,

Investigational New Drugs

2012

102

Phase I Dose-Finding Study of Pazopanib in Hepatocellular Carcinoma: Evaluation of Early Efficacy, Pharmacokinetics, and Pharmacodynamics

Thomas Yau, Pei‐Jer Chen, Pierre Chan,

Clinical Cancer Research

2011

88

Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma

Thomas Yau, Paul Cheng, Pierre Chan,

Investigational New Drugs

2015

79

The use of single‐agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child‐Pugh B liver cirrhosis

Joanne Wing Yan Chiu, Yuen Fong Tang, Tzy‐Jyun Yao,

Cancer

2012

67

The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)

Hilda Wong, Yuen Fong Tang, Tzy‐Jyun Yao,

The Oncologist

2011

67

Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease

Thomas Yau, Hilda Wong, Pierre Chan,

Investigational New Drugs

2012

65

Page 1